Patents by Inventor Jammieson Pires

Jammieson Pires has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODULATION OF NEUROGENESIS WITH GABA AGENTS AND GABA ANALOGS
    Publication number: 20110046090
    Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use of a GABA agent or GABA analog, in combination with one or more other neurogenic agents, to stimulate or activate the formation of new nerve cells.
    Type: Application
    Filed: August 20, 2010
    Publication date: February 24, 2011
    Applicant: BrainCells Inc.
    Inventors: Carrolee BARLOW, Todd Carter, Andrew Morse, Kai Treuner, Kym Lorrain, Jammieson Pires
  • MODULATION OF NEUROGENESIS BY NOOTROPIC AGENTS
    Publication number: 20070244143
    Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use of melatonin or other nootropic agent, optionally in combination with one or more other neurogenic agents, to stimulate or activate the formation of new nerve cells.
    Type: Application
    Filed: March 8, 2007
    Publication date: October 18, 2007
    Applicant: BrainCells, Inc
    Inventors: Carrolee Barlow, Todd Carter, Andrew Morse, Kai Treuner, Kym Lorrain, Dana Gitnick, Jammieson Pires
  • MODULATION OF NEUROGENESIS BY PDE INHIBITION
    Publication number: 20070208029
    Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use of a PDE agent, optionally in combination with one or more other neurogenic agents, to stimulate or activate the formation of new nerve cells.
    Type: Application
    Filed: October 20, 2006
    Publication date: September 6, 2007
    Applicant: BrainCells, Inc.
    Inventors: Carrolee Barlow, Todd Carter, Kym Lorrain, Jammieson Pires, Kai Treuner
  • GABA RECEPTOR MEDIATED MODULATION OF NEUROGENESIS
    Publication number: 20070112017
    Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use of a GABA agent, optionally in combination with one or more other neurogenic agents, to stimulate or activate the formation of new nerve cells.
    Type: Application
    Filed: October 30, 2006
    Publication date: May 17, 2007
    Applicant: BrainCells, Inc.
    Inventors: Carrolee Barlow, Todd Carter, Andrew Morse, Kym Lorrain, Jammieson Pires, Kai Treuner
  • MODULATION OF NEUORGENESIS BY HDac INHIBITION
    Publication number: 20070078083
    Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on an HDac inhibitory agent alone or in combination with another neurogenic agent to stimulate or activate the formation of new nerve cells.
    Type: Application
    Filed: September 7, 2006
    Publication date: April 5, 2007
    Applicant: BrainCells, Inc.
    Inventors: Carrolee Barlow, Todd Carter, Kym Lorrain, Jammieson Pires, Andrew Morse, Dana Gitnick, Kai Treuner, Alejandro Dearie
  • NEUROGENESIS BY MUSCARINIC RECEPTOR MODULATION
    Publication number: 20070049576
    Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on muscarinic receptor modulation, such as via inhibition of acetylcholine esterase (AChE) activity, alone or in combination with another neurogenic agent to stimulate or activate the formation of new nerve cells.
    Type: Application
    Filed: August 25, 2006
    Publication date: March 1, 2007
    Applicant: BrainCells, Inc.
    Inventors: Carrolee Barlow, Tood Carter, Kym Lorrain, Jammieson Pires, Andrew Morse, Dana Gitnick, Kai Treuner, Alex Broadhead
  • Methods for identifying agents and conditions that modulate neurogenesis
    Publication number: 20070015138
    Abstract: Methods and tools for identifying agents and conditions that modulate neurogenesis are disclosed. The disclosure also relates to methods and tools for identifying populations of neural stem cells suitable for transplantation.
    Type: Application
    Filed: July 7, 2006
    Publication date: January 18, 2007
    Applicant: BrainCells, Inc.
    Inventors: Carrolee Barlow, Jammieson Pires, Kym Lorrain, Todd Carter, Kai Treuner